Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Seoul National University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Hyo-Soo Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01605721
First received: July 18, 2011
Last updated: May 21, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)